According to Telix Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 31.6.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 21.9 | -23.19% |
2022-12-31 | 28.5 | -97.22% |
2021-12-31 | > 1000 | 7532.09% |
2020-12-31 | 13.4 | 139.46% |
2019-12-31 | 5.60 | 108.8% |
2018-12-31 | 2.68 |